Literature DB >> 15318508

Differentiation of faecal Escherichia coli from human and animal sources by random amplified polymorphic DNA-PCR (RAPD-PCR).

D Venieri1, A Vantarakis, G Komninou, M Papapetropoulou.   

Abstract

In this study the assessment of randomly amplified polymorphic DNA (RAPD) analysis was established as a molecular epidemiological tool. RAPD analysis was performed to differentiate faecal Escherichia coli isolates from human and animal sources. E. coli strains (128) were isolated from human and animal faeces (from cattle and sheep). Genomic DNA was extracted and randomly amplified polymorphic DNA-PCR (RAPD-PCR) fingerprinting was performed. Seven arbitrary primers were tested with a view to discriminating between E. coli isolates from humans and E. coli isolates from animals. RAPD profiles were analysed with hierarchical cluster analysis using an unweighted pair group method. RAPD profiles obtained with three of the tested primers (1247, 1290 and 1254) established a distinct differentiation between E. coli isolates from humans and E. coli from animals. Low levels of misclassification and high levels of specificity make RAPD a sensitive, efficient and reliable means of distinguishing closely related strains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15318508

Source DB:  PubMed          Journal:  Water Sci Technol        ISSN: 0273-1223            Impact factor:   1.915


  6 in total

1.  Detection of Antibiotic Resistance Determinants and Their Transmissibility among Clinically Isolated Carbapenem-Resistant Escherichia coli from South India.

Authors:  Niranjana Mahalingam; Bhavani Manivannan; Balaram Khamari; Shivakumara Siddaramappa; Sudeshna Adak; Eswarappa Pradeep Bulagonda
Journal:  Med Princ Pract       Date:  2018-05-08       Impact factor: 1.927

2.  Evaluation of different methods for extracting extracellular DNA from the biofilm matrix.

Authors:  Jianfeng Wu; Chuanwu Xi
Journal:  Appl Environ Microbiol       Date:  2009-06-26       Impact factor: 4.792

3.  Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections.

Authors:  Karen L Nielsen; Pia Dynesen; Preben Larsen; Lotte Jakobsen; Paal S Andersen; Niels Frimodt-Møller
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

4.  Selection of unique Escherichia coli clones by random amplified polymorphic DNA (RAPD): Evaluation by whole genome sequencing.

Authors:  Karen L Nielsen; Paul A Godfrey; Marc Stegger; Paal S Andersen; Michael Feldgarden; Niels Frimodt-Møller
Journal:  J Microbiol Methods       Date:  2014-06-06       Impact factor: 2.363

5.  Genomes of Escherichia coli bacteraemia isolates originating from urinary tract foci contain more virulence-associated genes than those from non-urinary foci and neutropaenic hosts.

Authors:  Adam P Dale; Anish K Pandey; Richard J Hesp; Konstantinos Belogiannis; Jay R Laver; Clifford C Shone; Robert C Read
Journal:  J Infect       Date:  2018-11-02       Impact factor: 6.072

6.  Complete genome sequence and comparative analysis of the wild-type commensal Escherichia coli strain SE11 isolated from a healthy adult.

Authors:  Kenshiro Oshima; Hidehiro Toh; Yoshitoshi Ogura; Hiroyuki Sasamoto; Hidetoshi Morita; Sang-Hee Park; Tadasuke Ooka; Sunao Iyoda; Todd D Taylor; Tetsuya Hayashi; Kikuji Itoh; Masahira Hattori
Journal:  DNA Res       Date:  2008-10-17       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.